Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES INC.

BRIGHT MINDS BIOSCIENCES clinical programs — 1063 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

1,063 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,063 programs

Clinical programs

Page 22 of 23

  1. Intravenous Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  2. Low strength nicotine e-liquid

    BRIGHT MINDS BIOSCIENCES INC.

    Electronic Cigarette Use

    small molecule terminated

    1 trial

  3. Low-fat milk group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial

  4. MDA

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    small molecule completed

    1 trial

  5. Mango

    BRIGHT MINDS BIOSCIENCES INC.

    Overweight or Obesity

    other completed

    1 trial

  6. Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    small molecule completed

    1 trial

  7. Methylphenidate HCl ER tablets 1

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Hyperactivity Disorder

    small molecule completed

    1 trial

  8. Morphine

    BRIGHT MINDS BIOSCIENCES INC.

    Sleep Deprivation

    small molecule completed

    1 trial

  9. Multivitamins

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    other completed

    1 trial

  10. Naltrexone and 2-butanol

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Adults

    small molecule completed

    1 trial

  11. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial

  12. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Major Depressive Disorder

    small molecule active

    1 trial

  13. Nicotine Replacement

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    small molecule active

    2 trials

  14. Nicotine Replacement Therapy (Habitrol)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  15. Nicotine Replacement Treatment (NRT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    small molecule completed

    1 trial

  16. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    small molecule completed

    1 trial

  17. Nicotine pod

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    small molecule completed

    1 trial

  18. Nut group

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolic Syndrome

    other completed

    1 trial

  19. Ondansetron

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Withdrawal

    small molecule completed

    1 trial

  20. Open Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Pain

    other active

    1 trial

  21. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  22. Paroxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    small molecule completed

    1 trial

  23. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    small molecule completed

    1 trial

  24. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorder

    small molecule completed

    1 trial

  25. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    2 trials

  26. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Magnetic Resonance Imaging

    small molecule completed

    1 trial

  27. Pregabalin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    small molecule terminated

    1 trial

  28. Preoperative Genotyping

    BRIGHT MINDS BIOSCIENCES INC.

    PPAP

    other active

    1 trial

  29. Probiotics

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    other terminated

    1 trial

  30. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Cessation

    small molecule completed

    1 trial

  31. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    small molecule completed

    1 trial

  32. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    small molecule completed

    2 trials

  33. RT-PCR Test

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    other completed

    1 trial

  34. Reduced Nicotine Content Cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    small molecule completed

    2 trials

  35. Rehabilitation Therapy as part of Standard of Care (Control)

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    gene therapy completed

    1 trial

  36. Sarcosine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    other completed

    1 trial

  37. Seromycin (D-cycloserine, DCS)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    small molecule completed

    1 trial

  38. Single dose of ibuprofen (800 mg tablet)

    BRIGHT MINDS BIOSCIENCES INC.

    Human Gastrointestinal Physiology Data

    small molecule completed

    1 trial

  39. Standard of Care medication for early Alzheimer's Disease

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    small molecule active

    1 trial

  40. Study Agent

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule active

    1 trial

  41. Tolcapone

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  42. Transdermal nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial

  43. Very Low Nicotine Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    small molecule active

    1 trial

  44. Very low nicotine cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial

  45. Vitamin D supplement

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    other completed

    1 trial

  46. Within-subjects (MDMA)

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    small molecule completed

    1 trial

  47. active nicotine gum

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule completed

    1 trial

  48. cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.